NIREZA Trademark

Trademark Overview

On Tuesday, June 12, 2012, a trademark application was filed for NIREZA with the United States Patent and Trademark Office. The USPTO has given the NIREZA trademark a serial number of 85649893. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 25, 2015. This trademark is owned by Glaxo Group Limited. The NIREZA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
nireza

General Information

Serial Number85649893
Word MarkNIREZA
Filing DateTuesday, June 12, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 25, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 28, 2012

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 21, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Tuesday, May 26, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 25, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 7, 2014EXTENSION 4 GRANTED
Wednesday, October 1, 2014EXTENSION 4 FILED
Wednesday, October 1, 2014TEAS EXTENSION RECEIVED
Friday, April 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 17, 2014EXTENSION 3 GRANTED
Wednesday, April 9, 2014EXTENSION 3 FILED
Wednesday, April 9, 2014TEAS EXTENSION RECEIVED
Friday, November 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2013EXTENSION 2 GRANTED
Wednesday, October 2, 2013EXTENSION 2 FILED
Wednesday, November 6, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 2, 2013TEAS EXTENSION RECEIVED
Tuesday, April 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 5, 2013EXTENSION 1 GRANTED
Friday, April 5, 2013EXTENSION 1 FILED
Friday, April 5, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 23, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 28, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 28, 2012PUBLISHED FOR OPPOSITION
Wednesday, August 8, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 25, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 25, 2012ASSIGNED TO LIE
Friday, July 13, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 13, 2012EXAMINER'S AMENDMENT ENTERED
Friday, July 13, 2012NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 13, 2012EXAMINERS AMENDMENT E-MAILED
Friday, July 13, 2012EXAMINERS AMENDMENT -WRITTEN
Wednesday, July 11, 2012ASSIGNED TO EXAMINER
Thursday, June 21, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 15, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

nireza pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological